Skip to main content
. 2013 Oct 1;36(11):641–648. doi: 10.1002/clc.22214

Table 2.

VLDL Database Structure

Naming Included Primary Purpose
Summation dataset VLDL First VAP test for each patient Large‐scale analyses; examination of rare or extreme phenotypes
3‐year interval dataset VLDL 2006–2008, VLDL 2009–2011, VLDL 2012–2014, and so on First VAP test for each patient in 3‐year intervals Large‐scale contemporary data analysis; secular trend assessment
Serial lab dataset VLDL‐S All VAP tests for patients with repeated testing Reproducibility of measurements; associations of changes in parameters
Ancillary datasets VLDL‐XXXX where XXXX is the other non‐VAP analyte (eg, VLDL‐ApoB, VLDL‐VitD, VLDL‐hsCRP) Samples with VAP plus another relevant analyte; nested within summation dataset Assessment of association of VAP test parameters with other analytes

Abbreviations: ApoB, apolipoprotein B; hsCRP, high‐sensitivity C‐reactive protein; VAP, Vertical Auto Profile; VitD, vitamin D; VLDL, Very Large Database of Lipids.